IDXG supply chain intelligence for Interpace Biosciences, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ASURAGEN-INC | ASURAGEN-INC | 92% | 10.20 Supply Agreement, dated August 13, 2014, by and between Interpace Diagnostics, LLC and Asuragen, Inc., incorporated by reference to Exhibit 10.33 of the Company’s Quarterly Report on Form 10-Q … |
| PRPH | ProPhase Labs, Inc. | 72% | Reciprocal relationship from PRPH graph: COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Bio… |
| QGEN | Qiagen N.V. | 72% | entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing strategies for most of these materials and vendors, we cannot be certain whether the… |
| QGEN | Qiagen N.V. | 72% | Reciprocal relationship from QGEN graph: Reciprocal relationship from IDXG graph: entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing st… |
| TMO | Thermo Fisher Scientific Inc. | 72% | tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of these items are unique to these suppliers and vendors. Our most significant supp… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from IDXG graph: tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| LABORATORY-CORPORATION-OF-AMERICA | LABORATORY-CORPORATION-OF-AMERICA | 92% | Our largest customer in 2025 for ThyGeNEXT ® and ThyraMIR ® v2 was Laboratory Corporation of America ® or LabCorp. |
| LABORATORY-CORPORATION-OF-AMERICA-OR-LABCORP | LABORATORY-CORPORATION-OF-AMERICA-OR-LABCORP | 92% | Our largest customer in 2025 for ThyGeNEXT ® and ThyraMIR ® v2 was Laboratory Corporation of America ® or LabCorp. | Qwen verified: Explicit commercial relationship stated with LabCorp as largest cus… |
| LH | Labcorp Holdings Inc. | 92% | Reciprocal relationship from LH graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from LH graph: Reciprocal relationship from IDXG graph: Our largest customer in 2025 for ThyGeN… |
| DGX | Quest Diagnostics Incorporated | 72% | Reciprocal relationship from DGX graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from DGX graph: Reciprocal relationship from IDXG graph: Reciprocal relationship from DGX grap… |
| DGX | Quest Diagnostics Incorporated | 72% | ublications, and trade show exhibits. We believe that our molecular diagnostic tests provide value to payers, physicians, and patients by improving patient care and lowering healthcare costs through … |
| PRPH | ProPhase Labs, Inc. | 72% | Reciprocal relationship from PRPH graph: COVID-19 and other RPP Molecular tests. Additionally, we compete against regional clinical laboratories providing diagnostic services, including Interpace Bio… |
| QGEN | Qiagen N.V. | 72% | Reciprocal relationship from QGEN graph: Reciprocal relationship from IDXG graph: entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing st… |
| QGEN | Qiagen N.V. | 72% | entific Inc., Illumina, Inc., Qiagen N.V., and F. Hoffmann-La Roche AG. While we have developed alternate sourcing strategies for most of these materials and vendors, we cannot be certain whether the… |
| TMO | Thermo Fisher Scientific Inc. | 72% | Reciprocal relationship from TMO graph: Reciprocal relationship from IDXG graph: tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of… |
| TMO | Thermo Fisher Scientific Inc. | 72% | tests from sole suppliers. We also purchase components used in our collection kits from sole-source suppliers. Some of these items are unique to these suppliers and vendors. Our most significant supp… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| IDXG-DEBT-10189 | Warrants outstanding: 875000 | 90% | xbrl warrant detail from xbrl 2021-12-31. |
| IDXG-DEBT-10190 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2022-12-31. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| CDNA | CareDx, Inc. | 100.00 | 2 | |
| IMTX | Immatics N.V. | 100.00 | 2 | |
| PRPH | ProPhase Labs, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| BHP | BHP Group Limited | 100.00 | 2 | |
| LH | Labcorp Holdings Inc. | 100.00 | 1 | ['customer'] |
| VRAX | Virax Biolabs Group Limited | 100.00 | 2 | |
| TWST | Twist Bioscience Corporation | 100.00 | 2 | |
| SOLV | Solventum Corporation | 100.00 | 2 | |
| PSNL | Personalis, Inc. | 100.00 | 2 | |
| BHPLF | BHP Group Limited | 100.00 | 2 | |
| CLLS | Cellectis S.A. | 100.00 | 2 | |
| IONS | Ionis Pharmaceuticals, Inc. | 100.00 | 2 | |
| MXCT | MaxCyte, Inc. | 100.00 | 2 | |
| ICLR | ICON Public Limited Company | 100.00 | 2 | |
| BTAI | BioXcel Therapeutics, Inc. | 100.00 | 2 | |
| AZTA | Azenta, Inc. | 100.00 | 2 | |
| STQN | Strategic Acquisitions, Inc. | 100.00 | 2 | |
| GH | Guardant Health, Inc. | 100.00 | 2 | |
| AETNA | AETNA | 63.48 | 1 | ['receiving'] |
| CIGNA | CIGNA | 63.48 | 1 | ['receiving'] |